Physician profile
Jay Meyer Bukzin
NPI 1740364066
$8,780.29
in general payments reported to CMS, 2019-2025
8 companies · $774 in 2025
The $774 reported for 2025 was more than what 83% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.61 · 2020: $120 · 2021: $368 · 2022: $481 · 2023: $5,512 · 2024: $1,466 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,760 · Entertainment: $1,917 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,760.22 |
| Entertainment | $1,916.73 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $7,257.78 | 2019-2025 | |
| Zimvie INC. | $854.85 | 2022-2025 | |
| Depuy Synthes Sales INC. | $261.10 | 2025 | Matrixorthognathic, Matrixmandible, Trumatch |
| Envista Holdings Corporation | $148.59 | 2024 | I-Cat Flx/Flx Mv |
| Zimmer Biomet Holdings, INC. | $130.00 | 2021 | |
| Kls-Martin L.P. | $85.90 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.59 | 2024 | Exparel |
| Southern Implants North America INC | $20.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Bukzin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.